Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells
S. Momsen Reincke, Niels von Wardenburg, Marie A. Homeyer, et al.
Cell (2023) Vol. 186, Iss. 23, pp. 5084-5097.e18
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases
Aiden Haghikia, Georg Schett, Dimitrios Mougiakakos
The Lancet Neurology (2024) Vol. 23, Iss. 6, pp. 615-624
Open Access | Times Cited: 21
Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies
Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, et al.
Antibodies (2024) Vol. 13, Iss. 1, pp. 10-10
Open Access | Times Cited: 18
Potential and pitfalls of repurposing the CAR-T cell regimen for the treatment of autoimmune disease
Andrea R. Daamen, Peter E. Lipsky
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 6, pp. 696-699
Closed Access | Times Cited: 14
Mechanisms of antibody-dependent enhancement of infectious disease
Timothy J. Wells, Tyron Esposito, Ian R. Henderson, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 12
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
Yi Song, Jian Li, Yuzhang Wu
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 12
Sequential immunotherapy: towards cures for autoimmunity
Francisco Ramírez‐Valle, Joseph Maranville, Sophie Roy, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 7, pp. 501-524
Closed Access | Times Cited: 10
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer
Michael Croft, Shahram Salek‐Ardakani, Carl F. Ware
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 939-961
Closed Access | Times Cited: 10
Toward curing neurological autoimmune disorders: Biomarkers, immunological mechanisms, and therapeutic targets
Yahel Segal‬‏, John Soltys, Benjamin D. Clarkson, et al.
Neuron (2025)
Closed Access | Times Cited: 1
Current advancements in cellular immunotherapy for autoimmune disease
Corbett T. Berry, C. Pritchett Frazee, Patrick J. Herman, et al.
Seminars in Immunopathology (2025) Vol. 47, Iss. 1
Open Access | Times Cited: 1
Precise recognition of benzonitrile derivatives with supramolecular macrocycle of phosphorylated cavitand by co-crystallization method
Heng Li, Zhijin Li, Lin Chen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
NMDA receptor autoantibodies primarily impair the extrasynaptic compartment
Zoë Jamet, Camille Mergaux, Morgane Meras, et al.
Brain (2024) Vol. 147, Iss. 8, pp. 2745-2760
Open Access | Times Cited: 6
B-cell targeted therapies in autoimmune encephalitis: mechanisms, clinical applications, and therapeutic potential
Haodong Shang, Xinru Shen, Xiaoxiao Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Precise Targeting of Autoantigen-Specific B Cells in Lupus Nephritis with Chimeric Autoantibody Receptor T Cells
Cristina Solé, María Royo, Sebastian Sandoval, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4226-4226
Open Access | Times Cited: 5
Mechanisms of autoimmune encephalitis
Claudia Papi, Chiara Milano, Marianna Spatola
Current Opinion in Neurology (2024) Vol. 37, Iss. 3, pp. 305-315
Closed Access | Times Cited: 5
Antibodies in neurological diseases: Established, emerging, explorative
Lucie Y. Li, Amelya Keles Slevogt, Marie A. Homeyer, et al.
Immunological Reviews (2024)
Open Access | Times Cited: 5
Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy in Neurology
Fatme Seval Ismail, Marco Gallus, Sven G. Meuth, et al.
JAMA Neurology (2024) Vol. 82, Iss. 1, pp. 93-93
Closed Access | Times Cited: 5
Engineered immune cells as therapeutics for autoimmune diseases
Moncef Zouali
Trends in biotechnology (2024) Vol. 42, Iss. 7, pp. 842-858
Closed Access | Times Cited: 4
Dawn of CAR-T cell therapy in autoimmune diseases
Yuxin Liu, Minghao Dong, Yun‐Hui Chu, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 10, pp. 1140-1150
Open Access | Times Cited: 4
CAR-engineered T cell therapy as an emerging strategy for treating autoimmune diseases
Jovana Vukovic, Džihan Abazović, Dusan Vucetic, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 4
Depletion of alloreactive B cells by drug- resistant chimeric alloantigen receptor T cells to prevent transplant rejection
Anna Christina Dragon, Agnes Bonifacius, Stefan Lienenklaus, et al.
Molecular Therapy (2025) Vol. 33, Iss. 3, pp. 1031-1047
Open Access
Rheumatoid arthritis unmasked: the power of B cell depletion therapy
Tawfeeq Alghazali, Raed Obaid Saleh, Subasini Uthirapathy, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Is there a place for engineered immune cell therapies in autoimmune diseases?
Luca Perico, Federica Casiraghi, Ariela Benigni, et al.
Trends in Molecular Medicine (2025)
Closed Access
Composition and function of AChR chimeric autoantibody receptor T cells for antigen-specific B cell depletion in myasthenia gravis
Sangwook Oh, Fatemeh Khani-Habibabadi, Kevin C. O’Connor, et al.
Science Advances (2025) Vol. 11, Iss. 9
Open Access
A new therapeutic pathway in autoimmune diseases: chimeric antigen receptor T cells (CAR-T) targeting specific cell subtypes or antigen-specific B lymphocytes—a brief review
María Fernanda Segovia, Diana Landoni, Yohana Defranchi, et al.
Exploration of Immunology (2025) Vol. 5
Open Access
The Clinical Trial Landscape in Autoimmune Encephalitis
Hesham Abboud, Stacey Clardy, Divyanshu Dubey, et al.
Neurology (2025) Vol. 104, Iss. 8
Closed Access
Page 1 - Next Page

Scroll to top